MedPath

Echocardiography Sub-Study of the Umbilical Cord Milking in Non-Vigorous Infants Trial (MINVI)

Not Applicable
Completed
Conditions
Birth Asphyxia
Registration Number
NCT03798093
Lead Sponsor
Sharp HealthCare
Brief Summary

Non-vigorous infants enrolled in the MINVI trial will be approached for consent for ongoing data collection. As part of the data collection, an optional echocardiogram will be performed if the parent consents.

Detailed Description

Non-vigorous infants enrolled in the MINVI trial will be approached for consent for ongoing data collection. As part of the data collection, an optional echocardiogram will be performed if the parent consents. The consent will have a check box to indicate if they consent to the additional test.

Echocardiographic measurements will be performed on all infants at 12 hours +/- 6 hours of age by our research sonographers who are blinded to infant randomization. Measurements will be taken according to a standard operating procedure to assess systemic blood flow, by superior vena cava (SVC) flow (ml/kg/min), right ventricular output (ml/kg/min), left ventricular output (LVO) (ml/kg/min), measures of left and right ventricular tissue Doppler and strain imaging. These measurements will be performed offline at a later time. Data will be entered into REDCap.

If any structural abnormalities are found, the attending pediatrician will be notified of the abnormal echocardiogram. The consent will clearly state that this echo is not for diagnostic purposes. Any additional studies including an official complete echocardiogram and or cardiology consultation will be left to the discretion of the attending pediatrician, as he/she deems necessary

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
227
Inclusion Criteria

• Non-vigorous newborns born between 35-42 weeks gestation.

Exclusion Criteria
  • Known major congenital or chromosomal anomalies of newborn.
  • Known cardiac defects other than small atrial septal defect (ASD), ventricular septal defect (VSD) and patent ductus arteriosus (PDA).
  • Complete placental abruption/cutting through the placenta at time of delivery.
  • Monochorionic multiples
  • Cord anomaly (i.e. cord avulsion or true knot)
  • Presence of non-reducible nuchal cord
  • Perinatal providers unaware of the protocol
  • Incomplete delivery data
  • Infants born in extremis, for whom additional treatment will not be offered.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Left Ventricular Output12 ± 6 hours of life

Left ventricular output measurements taken by cardiac ultrasound.

Secondary Outcome Measures
NameTimeMethod
Neonatal Right Ventricular Output12 ± 6 hours of life

Obtained from the modified short axis view of the neonatal echocardiogram performed at 12 hours of life ± 6 hours.

Neonatal Superior Vena Cava Flow12 ± 6 hours of life

superior vena cava (SVC) flow (Diameter obtained from the infraclavicular view (hybrid view) and doppler assessment from the subcostal view of the neonatal echocardiogram exam performed at 12 hours of life ± 6 hours.

Neonatal Peak Systolic Strain12 ± 6 hours of life

This measurement reflects the deformation (strain) of the heart muscle during systole (the phase of the heartbeat when the heart contracts) relative to its original length. More negative values indicate better myocardial function while values closer to 0 suggest impaired myocardial function.

Neonatal Peak Systolic Velocity12 ± 6 hours of life

Measure of left and right ventricular peak systolic tissue doppler velocity on neonatal echocardiogram performed at 12 hours of life ± 6 hours.

Trial Locations

Locations (1)

Sharp Mary Birch Hospital for Women and Newborns

🇺🇸

San Diego, California, United States

Sharp Mary Birch Hospital for Women and Newborns
🇺🇸San Diego, California, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.